Shengyuan Peptides

Catalog / GLP-1 & Metabolic Research / Tirzepatide

Tirzepatide research peptide — GLP-1 & Metabolic Research

Tirzepatide

Dual GIP and GLP-1 receptor agonist peptide for studying incretin synergy, nutrient metabolism, and body-weight regulation in laboratory models.

CAS Number2023788-19-2
Molecular Weight4813.5 Da
Purity99.2% (HPLC / MS verified)
CategoryGLP-1 & Metabolic Research
Quality metricsHPLC purity, peptide content, and identity are reported separately on the batch COA — see the purity guide.
StorageKeep lyophilized tirzepatide at -20°C protected from light and humidity, and handle opened vials under dry conditions to preserve integrity.
Research use only. Not for human or veterinary use. We do not provide dosing guidance or medical advice.
Request a Quote View Batch COA Data

About Tirzepatide

Tirzepatide is a synthetic dual-agonist peptide derived from a GIP scaffold with engineered GLP-1 receptor activity, carrying a C20 fatty-diacid moiety for albumin association in experimental settings. This hybrid design makes it a useful tool for dissecting how simultaneous GIPR and GLP-1R engagement shapes insulin secretion dynamics, glucagon regulation, gastric-emptying physiology, and energy metabolism. Preclinical researchers employ it to compare single- versus dual-receptor pharmacology, to interrogate downstream signaling in pancreatic beta cells and adipocytes, and to model incretin-based strategies in metabolic disease. Because potency across the two receptors depends on precise sequence fidelity, impurities from incomplete deprotection, oxidation of methionine and tryptophan residues, or backbone isomerization can distort assay readouts. Shandong Shengyuan therefore characterizes every lot by high-resolution LC-MS, reports RP-HPLC purity of at least 99.2%, and provides batch-specific certificates of analysis. Lyophilized product is offered strictly for research use only, not for human or veterinary use.

Research Applications

  • Dual incretin receptor signaling assays
  • Insulin and glucagon secretion studies
  • Gastric emptying physiology models
  • Adipocyte and hepatocyte metabolism research
  • Preclinical obesity and diabetes research

Quality & Documentation

Every batch of Tirzepatide is manufactured under our documented quality system and released with a Certificate of Analysis covering HPLC purity, mass spectrometry identity, peptide content, water content, and endotoxin. The batch code on your vial can be verified online in the COA lookup section of this site.

Related Products

Retatrutide Retatrutide Triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors, used to study integrated metabolic signaling and energy balance regulation. AOD9604 AOD9604 Modified human growth hormone fragment (177–191) investigated for lipolytic activity and metabolic pathway research in laboratory models.